Novacyt, an international specialist in clinical diagnostics, announces that the PROmate(r) COVID-19 1G(q32) real-time test has been approved in the UK under the provisions of the UK Health Safety Agency’s 2021 Regulations on medical devices (CTDA).
This test is the second direct PCR test and the company’s third product to be added to the CTDA’s register of approved products.
‘ The test is designed to detect a target gene of SARS-CoV-2 in ORF1ab and, like all of the Company’s direct PCR products, it does not require complex extraction solutions, manual or automated, which which dramatically improves laboratory workflow and reduces costs,” the company says.
Copyright (c) 2022 CercleFinance.com. All rights reserved.